Search

everythinglearnresearchcommunity

for

Search:↓

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Animal models are crucial for learning about hair loss and finding treatments.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

Some nonsurgical hair loss treatments are effective, especially if started early.

EF and PXE not closely related.

New method accurately measures finasteride in tablets.

No definitive link between finasteride and male breast cancer, but further research is needed.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

Androgenic Alopecia, a common hair loss condition, can be effectively treated with finasteride and other treatments.

Hair transplantation for men has improved, offering natural, lasting results, and may be enhanced by certain medications and future technologies.

New method accurately measures finasteride and M3 in urine, helping evaluate pharmacokinetics.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

Stopping finasteride can improve sperm count in infertile men.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Dutasteride is the most effective for hair loss but may cause sexual and mental side effects.

PRP can help treat hair loss but needs standardized methods for best results.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Finasteride lowers good cholesterol, raises bad fats, and may increase heart disease risk.

Pill splitting increased generic finasteride sales but didn't affect branded finasteride sales.

Finasteride users have a very low risk of mental health issues, but those with hair loss may have slightly higher anxiety and depression.

Finasteride and dutasteride do not significantly change beard thickness in men.

Dutasteride is more effective than finasteride for hair regrowth in male and female pattern hair loss, with similar side effects.